Indefinite Delivery Contract 36C24824D0056

Award Date 2/7/24
Last Date to Order 2/6/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $733,089.60 single-award IDC has an ultimate completion date of July 31, 2024 and does not utilize any set-aside designations. Under this IDC, Roche Diagnostics has been awarded multiple firm fixed price...
The key points are: This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) to Roche Diagnostics Corporation, a large business manufacturer and distributor of in-vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $991,073.55 IDC has a period of performance through September 30, 2024 and provides a vehicle for VISN 9 to acquire reagents, test kits, test sets, and...
This Indefinite Delivery Contract was awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 8 (VISN 8) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $1,317,236.75 and a period of performance through September 30, 2025. The contract is for the provision of histology staining services and is not set aside....
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 9 to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $470,851.70, is for the delivery of Roche HE600 reagents over a period ending on September 30, 2029. This delivery order is part of a larger IDC held by Roche to supply chemistry reagents to VA and military treatment facilities across a...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 17, to Roche Diagnostics Corporation for the provision of Roche Ventana reagents and consumables. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to various federal agencies, including the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
This Indefinite Delivery Contract (IDC) award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides the Defense Health Agency (DHA) with a long-term vehicle to acquire various laboratory instruments, reagents, test kits, and associated products and services. The $1.77 million ceiling value contract has a period of performance through September 2026. Multiple delivery orders have been placed against this IDC, including $354,965 for Roche reagents in FY 2023,...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
  • 36C24824D0056
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

This is a single award indefinite delivery contract (IDC) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $747,152.59 ceiling value IDC has an ultimate completion date of February 6, 2029 and will provide a histology staining system and associated consumables, parts, and services on a cost-per-test basis to the VA's Caribbean Healthcare System in San Juan, Puerto Rico. The IDC was awarded under an unrestricted solicitation issued by the VA's Network Contracting Office 8 in Orlando, with the primary NAICS code of 325413 for in-vitro diagnostic substance manufacturing. A $299,638.15 firm fixed-price delivery order has been issued under the IDC to supply the histology staining system, with a completion date of February 6, 2025. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated medical products and services to various federal agencies through IDCs, blanket purchase agreements, and subcontracts.

Generated 2/6/25, 9:03 AM